Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Lumora Names Reid as Chairman; Evogen Promotes St. Clair

Premium

Lumora has appointed Jim Reid as chairman.

Reid has spent more than 35 years in the bioscience and diagnostic industries in a number of positions at companies such as Organon, Bioscot, Roche, Chiron, and Trinity Biotech. He also holds a number of non-executive director positions, including with Sistemic, Ocutec, and BioFilm.


Evogen has named Richard St. Clair as vice president of commercialization.

St. Clair previously served as director of marketing and business development at Evogen. He will be responsible commercializing Evogen and Sceptor products for the healthcare, biodefense, and industrial markets.

St. Clair holds a BA in human biology from the University of Kansas and an MBA from Webster University.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.